We have detected that you are using an Ad Blocker.
PracticeUpdate is free to end users but we rely on advertising to fund our site. Please consider supporting PracticeUpdate by whitelisting us in your ad blocker.
We have sent a message to the email address you have provided, . If this email is not correct, please update your settings with your correct address.
The email address you provided during registration, , does not appear to be valid. Please update your settings with a valid address before to continue using PracticeUpdate.
Please provide your AHPRA Number to ensure that you are given the correct level of access to our site.
Philippe Pibarot DVM, PhD, FAHA, FACC, FESC, FASE

Philippe Pibarot DVM, PhD, FAHA, FACC, FESC, FASE

Professor, Department of Medicine, Laval University; Chair, Canada Research in Valvular Heart Diseases, Québec Heart and Lung Institute, Québec, Québec, Canada

Philippe Pibarot obtained a doctorate in veterinary medicine (DVM) in 1987 at the University Claude Bernard in Lyon, France and a PhD degree in biomedical sciences from the University of Montreal in April 1995. He is professor at the Department of Medicine of Laval University and holds the Canada Research Chair in Valvular Heart Disease (VHD) at the Québec Heart & Lung Institute. The objective of his research program is to develop and validate novel approaches to improve the diagnosis, prevention, and treatment of VHD. He is currently the principal investigator of 3 multicenter studies funded by Canadian Institutes of Health Research and the Heart and Stroke Foundation of Québec. He has published more than 300 articles and presented 290 invited conferences in the course of his career. He is associate editor for the Journal of the American Society of Echocardiography. He received the Annual Achievement Award of the Canadian Society of Echocardiography (2010), the Research Achievement Award, Canadian Cardiovascular Society (2010), and the Feigenbaum Lecture Award, American Society of Echocardiography (2012).